Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
56,080,885
-
Share change
-
+24,786,699
-
Total reported value
-
$121,137,540
-
Put/Call ratio
-
241%
-
Price per share
-
$2.16
-
Number of holders
-
75
-
Value change
-
+$55,077,247
-
Number of buys
-
46
-
Number of sells
-
21
Institutional Holders of MARINUS PHARMACEUTICALS INC - COM (MRNS) as of Q4 2019
As of 31 Dec 2019,
MARINUS PHARMACEUTICALS INC - COM (MRNS) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,080,885 shares.
The largest 10 holders included
Lion Point Capital, LP, Avoro Capital Advisors LLC, Bain Capital Life Sciences Investors, LLC, VHCP Management III, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BOXER CAPITAL, LLC, BlackRock Inc., VANGUARD GROUP INC, Granite Point Capital Management, L.P., and Alyeska Investment Group, L.P..
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.